Two measures of patient well-being, designed for use in busy clinical ... and colleagues in the Veterans Health ...

The company’s lead indication area is cardiogenic shock (which is a severe form of heart ... Based on the patient’s condition ...

After an unexpected fall led to hip surgery, maybe your 85-year-old father thought he'd be back to his routine in no time. His doctor, however, says it's not safe for him to discharge home. He' ...

This transformative gift from Ted W. Love, M.D., and Joyce Y. Love will improve patient care for those with sickle cell ...

A nurse who had a relationship with a patient at a high-security psychiatric hospital before resuming it years later has been ...

The effects of war on those who fight and witness it firsthand can linger long after peace has been made and the troops have ...

Last Patient Enrolled for Planned Unblinded Interim Analysis in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 Unblinded Interim Analysis Outcome ...

Since Blueprint Medicines’ inception over a decade ago, we have focused on advancing the understanding of the underlying ...

A team at London Health Sciences Centre Research Institute (LHSCRI) is the first in Canada to treat a patient with ...

QNRX READ THE FULL QNRX RESEARCH REPORT U.S. and International Sites participating in QRX003 NS study, Expanding to study QRX003 for additional indications and in younger patient populations Quoin ...

Patient engagement is a necessity when performing health technology assessment to help better assess and identify the outcomes of a rare disease.

This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...